Haoxi Health Valuation
| HAO Etf | USD 1.80 0.12 6.25% |
Based on Macroaxis valuation methodology, the entity appears to be overvalued. Haoxi Health Technology retains a regular Real Value of $1.76 per share. The prevalent price of the entity is $1.8. Our model calculates the value of Haoxi Health Technology from evaluating the entity fundamentals such as Return On Equity of 0.2, return on asset of 0.11, and Current Valuation of (402.08 K) as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 0.4482 | Enterprise Value -402.1 K | Enterprise Value Ebitda 17.368 | Price Sales 0.1041 | Trailing PE 1.79 |
Overvalued
Today
Please note that Haoxi Health's price fluctuation is extremely dangerous at this time. Calculation of the real value of Haoxi Health Technology is based on 3 months time horizon. Increasing Haoxi Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Haoxi Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Haoxi Etf. However, Haoxi Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.8 | Real 1.76 | Hype 1.79 | Naive 1.92 |
The intrinsic value of Haoxi Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Haoxi Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Haoxi Health Technology helps investors to forecast how Haoxi etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Haoxi Health more accurately as focusing exclusively on Haoxi Health's fundamentals will not take into account other important factors: Haoxi Health Total Value Analysis
Haoxi Health Technology is currently forecasted to have company total value of (402.08 K) with market capitalization of 5.05 M, debt of 1.2 M, and cash on hands of . The negative valuation of Haoxi Health may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Haoxi Health fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(402.08 K) | 5.05 M | 1.2 M |
Haoxi Health Investor Information
The fund retains 99.27% of assets under management (AUM) in equities. Haoxi Health Technology last dividend was 0.009 per share. Haoxi Health Technology is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in April.Haoxi Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Haoxi Health has an asset utilization ratio of 312.9 percent. This suggests that the ETF is making $3.13 for each dollar of assets. An increasing asset utilization means that Haoxi Health Technology is more efficient with each dollar of assets it utilizes for everyday operations.Haoxi Health Ownership Allocation
Haoxi Health secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Haoxi Health Profitability Analysis
The company reported the last year's revenue of 48.52 M. Total Income to common stockholders was 1.29 M with profit before taxes, overhead, and interest of 2.75 M.About Haoxi Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Haoxi Health Technology. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of Haoxi Health Technology based exclusively on its fundamental and basic technical indicators. By analyzing Haoxi Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Haoxi Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Haoxi Health. We calculate exposure to Haoxi Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Haoxi Health's related companies.Haoxi Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 30.6 M | |
| Quarterly Earnings Growth Y O Y | -0.037 |
Other Information on Investing in Haoxi Etf
Haoxi Health financial ratios help investors to determine whether Haoxi Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haoxi with respect to the benefits of owning Haoxi Health security.